These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19021070)

  • 1. Complete remission and virologic response to combined chemoimmunotherapy (R-CVP) followed by rituximab maintenance in HIV-negative, HHV-8 positive patient with multicentric Castleman disease.
    Fragasso A; Mannarella C; Ciancio A; Calvario A; Scarasciulli ML
    Leuk Lymphoma; 2008 Nov; 49(11):2224-6. PubMed ID: 19021070
    [No Abstract]   [Full Text] [Related]  

  • 2. Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman's disease induced with anti-CD20.
    Cervera Grau JM; Galiana Esquerdo G; Llorca Ferrándiz C; Briceño García H; Díaz Castellano M; Férriz Moreno P
    Clin Transl Oncol; 2006 Jul; 8(7):540-1. PubMed ID: 16870545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-associated multicentric Castleman disease.
    Oksenhendler E
    Curr Opin HIV AIDS; 2009 Jan; 4(1):16-21. PubMed ID: 19343828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient.
    Law AB; Ryan G; Lade S; Prince HM
    Int J Hematol; 2010 Mar; 91(2):347-8; author reply 349. PubMed ID: 20146033
    [No Abstract]   [Full Text] [Related]  

  • 5. Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease.
    Powles T; Stebbing J; Montoto S; Nelson M; Gazzard B; Orkin C; Webb A; Bower M
    Blood; 2007 Dec; 110(12):4132-3. PubMed ID: 18024800
    [No Abstract]   [Full Text] [Related]  

  • 6. Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.
    Peker D; Martinez AE; Schwartz MA; Cusnir M
    Clin Adv Hematol Oncol; 2012 Mar; 10(3):204-6. PubMed ID: 22402431
    [No Abstract]   [Full Text] [Related]  

  • 7. Brief communication: rituximab in HIV-associated multicentric Castleman disease.
    Bower M; Powles T; Williams S; Davis TN; Atkins M; Montoto S; Orkin C; Webb A; Fisher M; Nelson M; Gazzard B; Stebbing J; Kelleher P
    Ann Intern Med; 2007 Dec; 147(12):836-9. PubMed ID: 18087054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.
    Nicoli P; Familiari U; Bosa M; Allice T; Mete F; Morotti A; Cilloni D; Saglio G; Guerrasio A
    Int J Hematol; 2009 Oct; 90(3):392-396. PubMed ID: 19756920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab therapy for HIV-associated Castleman disease.
    Marcelin AG; Aaron L; Mateus C; Gyan E; Gorin I; Viard JP; Calvez V; Dupin N
    Blood; 2003 Oct; 102(8):2786-8. PubMed ID: 12842986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of iatrogenic multicentric Castleman's disease arising due to recrudescence of HHV-8 in a liver transplant patient.
    Speicher DJ; Sehu MM; Mollee P; Shen L; Johnson NW; Faoagali JL
    Am J Transplant; 2014 May; 14(5):1207-13. PubMed ID: 24674650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy.
    Corbellino M; Bestetti G; Scalamogna C; Calattini S; Galazzi M; Meroni L; Manganaro D; Fasan M; Moroni M; Galli M; Parravicini C
    Blood; 2001 Dec; 98(12):3473-5. PubMed ID: 11719390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBV+ HHV-8+ Multicentric Castleman Disease With Plasmablastic Aggregates in an HIV+ Man: An Evolving Clinicopathologic Entity.
    Shivane A; Pearce A; Khatib N; Smith MEF
    Int J Surg Pathol; 2018 Jun; 26(4):338-341. PubMed ID: 29198143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of Castleman disease.
    Lomas OC; Streetly M; Pratt G; Cavet J; Royston D; Schey S; Ramasamy K;
    Br J Haematol; 2021 Nov; 195(3):328-337. PubMed ID: 34340261
    [No Abstract]   [Full Text] [Related]  

  • 14. How I treat HHV8/KSHV-related diseases in posttransplant patients.
    Riva G; Luppi M; Barozzi P; Forghieri F; Potenza L
    Blood; 2012 Nov; 120(20):4150-9. PubMed ID: 22968461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease.
    Bower M; Veraitch O; Szydlo R; Charles P; Kelleher P; Gazzard B; Nelson M; Stebbing J
    Blood; 2009 May; 113(19):4521-4. PubMed ID: 19224759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus-associated multicentric Castleman disease refractory to antiretroviral therapy: clinical features, treatment and outcome.
    Alzahrani M; Hull MC; Sherlock C; Griswold D; Leger CS; Leitch HA
    Leuk Lymphoma; 2015 May; 56(5):1246-51. PubMed ID: 25093377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.
    Uldrick TS; Polizzotto MN; Aleman K; Wyvill KM; Marshall V; Whitby D; Wang V; Pittaluga S; O'Mahony D; Steinberg SM; Little RF; Yarchoan R
    Blood; 2014 Dec; 124(24):3544-52. PubMed ID: 25331113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of multicentric Castleman's disease with bilateral orbital tumour using rituximab.
    Ide M; Ogawa E; Kasagi K; Kawachi Y; Ogino T
    Br J Haematol; 2003 Jun; 121(5):818-9. PubMed ID: 12780800
    [No Abstract]   [Full Text] [Related]  

  • 19. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
    Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.
    Casper C; Nichols WG; Huang ML; Corey L; Wald A
    Blood; 2004 Mar; 103(5):1632-4. PubMed ID: 14615380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.